Cargando…

Impact of COVID-19 pneumonia on pulmonary vascular volume

BACKGROUND: Pulmonary manifestations of COVID-19 pneumonia are well known. However, COVID-19 is also associated with a range of vascular manifestations such as embolism, congestion, and perfusion changes. Regarding congestion, research from different groups has suggested arteriovenous anastomosis dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Fahrni, Guillaume, Rocha, Ana-Carolina, Gudmundsson, Louis, Pozzessere, Chiara, Qanadli, Salah D., Rotzinger, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073514/
https://www.ncbi.nlm.nih.gov/pubmed/37035332
http://dx.doi.org/10.3389/fmed.2023.1117151
_version_ 1785019584875593728
author Fahrni, Guillaume
Rocha, Ana-Carolina
Gudmundsson, Louis
Pozzessere, Chiara
Qanadli, Salah D.
Rotzinger, David C.
author_facet Fahrni, Guillaume
Rocha, Ana-Carolina
Gudmundsson, Louis
Pozzessere, Chiara
Qanadli, Salah D.
Rotzinger, David C.
author_sort Fahrni, Guillaume
collection PubMed
description BACKGROUND: Pulmonary manifestations of COVID-19 pneumonia are well known. However, COVID-19 is also associated with a range of vascular manifestations such as embolism, congestion, and perfusion changes. Regarding congestion, research from different groups has suggested arteriovenous anastomosis dysregulation as a contributing factor. In this study, we aim to better describe the changes in vascular volume in affected lung zones and to relate them to pathophysiological hypotheses. METHODS: We performed automatic vascular volume extraction in 10 chest CTs of patients, including 2 female and 8 male with a mean age of 63.5 ± 9.3 years, diagnosed with COVID-19 pneumonia. We compared the proportion of vascular volumes between manually segmented regions of lung parenchyma with and without signs of pneumonia. RESULTS: The proportion of vascular volume was significantly higher in COVID (CVasc) compared to non-COVID (NCVasc) areas. We found a mean difference (DVasc) of 5% and a mean ratio (RVasc) of 3.7 between the two compartments (p < 0.01). CONCLUSION: Vascular volume in COVID-19 affected lung parenchyma is augmented relative to normal lung parenchyma, indicating venous congestion and supporting the hypothesis of pre-existing intra-pulmonary arteriovenous shunts.
format Online
Article
Text
id pubmed-10073514
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100735142023-04-06 Impact of COVID-19 pneumonia on pulmonary vascular volume Fahrni, Guillaume Rocha, Ana-Carolina Gudmundsson, Louis Pozzessere, Chiara Qanadli, Salah D. Rotzinger, David C. Front Med (Lausanne) Medicine BACKGROUND: Pulmonary manifestations of COVID-19 pneumonia are well known. However, COVID-19 is also associated with a range of vascular manifestations such as embolism, congestion, and perfusion changes. Regarding congestion, research from different groups has suggested arteriovenous anastomosis dysregulation as a contributing factor. In this study, we aim to better describe the changes in vascular volume in affected lung zones and to relate them to pathophysiological hypotheses. METHODS: We performed automatic vascular volume extraction in 10 chest CTs of patients, including 2 female and 8 male with a mean age of 63.5 ± 9.3 years, diagnosed with COVID-19 pneumonia. We compared the proportion of vascular volumes between manually segmented regions of lung parenchyma with and without signs of pneumonia. RESULTS: The proportion of vascular volume was significantly higher in COVID (CVasc) compared to non-COVID (NCVasc) areas. We found a mean difference (DVasc) of 5% and a mean ratio (RVasc) of 3.7 between the two compartments (p < 0.01). CONCLUSION: Vascular volume in COVID-19 affected lung parenchyma is augmented relative to normal lung parenchyma, indicating venous congestion and supporting the hypothesis of pre-existing intra-pulmonary arteriovenous shunts. Frontiers Media S.A. 2023-03-22 /pmc/articles/PMC10073514/ /pubmed/37035332 http://dx.doi.org/10.3389/fmed.2023.1117151 Text en Copyright © 2023 Fahrni, Rocha, Gudmundsson, Pozzessere, Qanadli and Rotzinger. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Fahrni, Guillaume
Rocha, Ana-Carolina
Gudmundsson, Louis
Pozzessere, Chiara
Qanadli, Salah D.
Rotzinger, David C.
Impact of COVID-19 pneumonia on pulmonary vascular volume
title Impact of COVID-19 pneumonia on pulmonary vascular volume
title_full Impact of COVID-19 pneumonia on pulmonary vascular volume
title_fullStr Impact of COVID-19 pneumonia on pulmonary vascular volume
title_full_unstemmed Impact of COVID-19 pneumonia on pulmonary vascular volume
title_short Impact of COVID-19 pneumonia on pulmonary vascular volume
title_sort impact of covid-19 pneumonia on pulmonary vascular volume
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073514/
https://www.ncbi.nlm.nih.gov/pubmed/37035332
http://dx.doi.org/10.3389/fmed.2023.1117151
work_keys_str_mv AT fahrniguillaume impactofcovid19pneumoniaonpulmonaryvascularvolume
AT rochaanacarolina impactofcovid19pneumoniaonpulmonaryvascularvolume
AT gudmundssonlouis impactofcovid19pneumoniaonpulmonaryvascularvolume
AT pozzesserechiara impactofcovid19pneumoniaonpulmonaryvascularvolume
AT qanadlisalahd impactofcovid19pneumoniaonpulmonaryvascularvolume
AT rotzingerdavidc impactofcovid19pneumoniaonpulmonaryvascularvolume